Consumer Healthcare Products Association thanks Washington State gov for signing SSHB 2163 bill

NewsGuard 100/100 Score

The Consumer Healthcare Products Association thanks Washington State Governor Jay Inslee for signing SSHB 2163 and Rep. Paul Harris for the initial introduction of the legislation. The legislation will prohibit retail outlets from selling over-the-counter (OTC) cough medicines containing dextromethorphan (DXM) to those under 18 without a prescription.

"The makers of over-the-counter medicines want to acknowledge Governor Inslee, Rep. Paul Harris and the Washington State legislature for taking a major step to address teen cough medicine abuse," CHPA President and CEO Scott Melville said. "The passage of similar legislation in states across the country indicates that there is a growing support for this measure. We hope this action in Washington State will help generate further support for a national law."

According to the 2013 National Institute on Drug Abuse's (NIDA) Monitoring the Future Survey, approximately one in 25 teens abuses DXM to get high.

"As a proud Washingtonian, my objective was to enact legislation that would address the key factor in this dangerous behavior, ease of access. By prohibiting teens from purchasing these medicines on their own, without their parents' knowledge, we can deter them from engaging in this behavior," said Harris.

Upon enactment of this bill, Washington will join Virginia, California, and New York as the fourth state to place an age-18 restriction on DXM sales.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Navigating the minefield of AI in healthcare: Balancing innovation with accuracy